Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

Clinical trial NCT00426803 · COMPLETED

Trial details

NCT number: NCT00426803
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Intracerebral Haemorrhage

Start date: 2002-08-01
Primary completion: 2004-06-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.